Furthermore, pharmacological stimulation of PPARγ leads to an elevation in the production of fatty acid binding protein 4 (FABP4), which is followed by an increase in the amount of reactive oxygen species in lung cancer cells. The gene discussed is PPARG; the disease is lung carcinoma.